Brazil brings advanced therapy GMP regulations into line with international standards.
Anvisa, Brazil’s medicines regulator, has updated the country’s good manufacturing practices (GMP) for advanced therapies based on standards issued by PIC/S, the Pharmaceutical Inspection Convention and the Pharmaceutical Inspection Co-operation Scheme.
Regulation IN 270/2023 will complement the regulatory framework for advanced therapies and guidelines on GMP and good practices for human...
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
The UK regulator approved 16 medicines containing a new active substance in the first half of this year, while the European Commission issued marketing authorizations for 20 NAS-containing drugs.
Joint clinical assessment reports must be descriptive rather than reach definitive conclusions, and must not interfere with national decision making processes, according to new EU guidance.
The agency’s plan for advanced manufacturing seeks more harmonization, while also seeking to codify internal practices with guidance and training.
Joint clinical assessment reports must be descriptive rather than reach definitive conclusions, and must not interfere with national decision making processes, according to new EU guidance.
Developments in India and Pakistan are designed to standardize how drug companies disclose their expenses associated with health care professionals.
The agency’s plan for advanced manufacturing seeks more harmonization, while also seeking to codify internal practices with guidance and training.
